Companies and entities

A spin-off from the ICMAB-CSIC that uses nanotechnology to prevent the falsification of drugs. The technology enables the control of the nanostructure of the printed elements on the surface of the product based on the molecular orientation and composition of the materials. The central idea is that the stamped security element will only be revealed when observed with a simple polarisation system.

A multinational corporation specialised in transport and mobility. The company is present in three continents, with Spain, France, and Saudi Arabia being the main markets, and has over 7,000 professionals.
It is a company based at the Edifici Eureka from the Parc de Recerca UAB that develops scalable solutions in bioinformatica and sequencing technology and innovative strategies to identify microorganisms and resistances to antimicrobes from a OneHealth point of view.

A tecnhology-based company from the UAB, created to develop nanomedicine for treating cancer via the selective elimination of tumoral cells. It is a system based on nanoparticles that transport a chemotherapeutic drug and release it into cancer cells.

It is a spin-off from the Institut de Ciència de Materials de Barcelona (ICMAB) at the CSIC. It offers R&D&I services and advanced technology to generate new nanomedicines and drug administration solutions that allow for better therapeutic efficacy and the comfort of the patient during their treatment.

Company offering services, technology, and automation to online food supplier businesses around the world.

It is a spin-off from the Centre de Visió per Computador (CVC), intending to give intelligence to machines, supplies, and passive equipment for better communication and interaction with people.

It is a spin-off from the ’Institut Català de Nanociència i Nanotecnologia (ICN2) adhered to the Parc de Recerca UAB. Promoted by Prof. ICREA Arben Merkoçi, responsible for the ICN2's Grup de Nanobioelectrònica i Biosensors, and innovation expert Marc Gallegos, PhD. The company has developed a low-cost, easy-to-use dispositive to identify drug-induced lesions.
A spin-off from the CRAG that develops and commercialises products for sustainable agriculture, designed to mitigate the rapid effects of climate change. Their patented technology opens a door to sustainable and efficient solutions to the droughts and heat waves in the fields.

It is a company based in the Edifici Eureka at the Parc de Recerca UAB focused on the research and development of new products for in vitro diagnosis. The company offers consulting services and R&D labs to established companies, spin-offs, and start-ups to help introduce new products to the in vitro fertilization market.

A deep-tech spin-off from the Institut de Física d’Altes Energies (IFAE), the Universitat de Barcelona (UB), and the Barcelona Supercomputing Center (BSC) which addresses real-life quantum prepared problems. Both hardware and software are centered around a high-quality, quantum reaction qubit architecture to offer both quantum processors and servers.

It is a biotech company developing new treatments for antibody-generated diseases and dysfunctions; their platform allows the elimination of antibodies to give therapeutic solutions in infectious or autoimmune diseases, allergies and other fields where antibodies can affect.
A technology-based company from the Centre de Recerca Matemàtica (CRM). RheoDx is a precise and portable in vitro device that immediately diagnoses hematological diseases with a single drop of blood.
Pharmaceutical company with headquarters in Basilea and Paris that produces and commercialises drugs, vitamins, and other products, as well as services such as diagnosis and exams.

It is a company located at the Edifici Eureka from the Parc de Recerca UAB that has developed and patented new SMART UV solar filters that act depending on the UV radiation dose. The new filters have been incorporated into a new generation of solar products with on-demand protection.

SENER is a Spanish engineering and technology private group with activity in aerospatial, defence, energy, and mobility and infrastructure markets, and advanced installations such as naval, digital, health, and data centres.

Located at the Edifici Eureka of the Parc de Recerca UAB, it offers innovative solutions to accompany clients in transitioning from a linear model that over consumes our resources to a circular economy that recycles and uses them properly. It contributes to the sustainable development of the communities where it is present.

This spin-off from the Institut de Microelectrònica de Barcelona del CSIC (IMB-CNM) is dedicated to the design, fabrication and distribution of products and tecnhonolgies to analyze the composition of sweat and other biological fluids.

Born in the Sostenipra research group, from the Institut de Ciència i Tecnologia Ambientals at the Universitat Autònoma de Barcelona, they are specialists in urban agriculture and have many expertises to be able to give an interdisciplinary answer to the challenges that come to make cities more sustainable.

A spin-off from the Centre Nacional d’Investigacions Oncològiques (CNIO) and the Universitat Autònoma de Barcelona (UAB) to develop a new telomerase gene therapy for the treatment of lung fibrosis.

Tradebe is a company managing a diverse array of businesses specialised in environment services, life sciences, port services, and health and nutrition.

Main public transport operator in Catalonia. TMB is the common denominator of the companies Ferrocarril Metropolità de Barcelona, SA, and Transports de Barcelona, SA. It also includes the companies Projectes i Serveis de Mobilitat SA and Transports Metropolitans de Barcelona SL.

A technology-based company from the UAB located at the Edifici Eureka of the Parc de Recera UAB, that specializes in veterinarian genetic diagnosis.

It is a spin-off from CVC that offers video analysis solutions based on IA that transform a video from any source into secure, personalised actionable intelligence that allows their clients to create and maintain the world's most productive and secure organisations.